133 related articles for article (PubMed ID: 26666748)
1. Effect of 24 Cytochrome P450 2D6 Variants Found in the Chinese Population on Atomoxetine Metabolism in vitro.
Liang B; Zhan Y; Wang Y; Gu E; Dai D; Cai J; Hu G
Pharmacology; 2016; 97(1-2):78-83. PubMed ID: 26666748
[TBL] [Abstract][Full Text] [Related]
2. Identification of the human cytochromes P450 responsible for atomoxetine metabolism.
Ring BJ; Gillespie JS; Eckstein JA; Wrighton SA
Drug Metab Dispos; 2002 Mar; 30(3):319-23. PubMed ID: 11854152
[TBL] [Abstract][Full Text] [Related]
3. Effects of 22 CYP2D6 Genetic Variations Newly Identified in Chinese Population on Olanzapine Metabolism in vitro.
Zhou HY; Gu EM; Chen QL; Zhan YY; Wang SH; Liang BQ; Dai DP; Cai JP; Hu GX
Pharmacology; 2016; 98(3-4):124-33. PubMed ID: 27251229
[TBL] [Abstract][Full Text] [Related]
4. Simple pharmacokinetic models accounting for drug monitoring results of atomoxetine and its 4-hydroxylated metabolites in Japanese pediatric patients genotyped for cytochrome P450 2D6.
Notsu Y; Shimizu M; Sasaki T; Nakano A; Ota M; Yoshida S; Yamazaki H
Drug Metab Pharmacokinet; 2020 Apr; 35(2):191-200. PubMed ID: 32184039
[TBL] [Abstract][Full Text] [Related]
5. Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro.
Liang B; Zhan Y; Huang X; Gu E; Dai D; Cai J; Hu G
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):759-765. PubMed ID: 26542054
[TBL] [Abstract][Full Text] [Related]
6. Effect of 22 CYP2D6 variants found in the Chinese population on tolterodine metabolism in vitro.
Wang H; Dai DP; Sun P; Xu LP; Liang BQ; Cai JP; Hu GX
Chem Biol Interact; 2017 Feb; 264():10-15. PubMed ID: 28087463
[TBL] [Abstract][Full Text] [Related]
7. Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine.
Xu RA; Gu EM; Zhou Q; Yuan L; Hu X; Cai J; Hu G
Drug Des Devel Ther; 2016; 10():687-96. PubMed ID: 26937172
[TBL] [Abstract][Full Text] [Related]
8. Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.
Wang Z; Wang L; Xu RA; Zhan YY; Huang CK; Dai DP; Cai JP; Hu GX
Drug Des Devel Ther; 2016; 10():1909-16. PubMed ID: 27354764
[TBL] [Abstract][Full Text] [Related]
9. Effects of 24 CYP2D6 Variants Found in the Chinese Population on the Metabolism of Risperidone.
Wang ZH; Zhan YY; Li YX; Yang CC; Cai J; Dai DP; Hu GX; Cai JP
Pharmacology; 2015; 96(5-6):290-5. PubMed ID: 26544071
[TBL] [Abstract][Full Text] [Related]
10. Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes.
Jung EH; Lee YJ; Kim DH; Kang P; Lim CW; Cho CK; Jang CG; Lee SY; Bae JW
Arch Pharm Res; 2020 Dec; 43(12):1356-1363. PubMed ID: 33245517
[TBL] [Abstract][Full Text] [Related]
11. Effect of 24 cytochrome P450 2D6 variants found in the Chinese population on the N-demethylation of amitriptyline in vitro.
Weng Q; Liang B; Zhou Y; Li X; Wang H; Zhan Y; Dai D; Cai J; Hu G
Pharm Biol; 2016 Nov; 54(11):2475-2479. PubMed ID: 27097346
[TBL] [Abstract][Full Text] [Related]
12. Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites.
Byeon JY; Kim YH; Na HS; Jang JH; Kim SH; Lee YJ; Bae JW; Kim IS; Jang CG; Chung MW; Lee SY
Arch Pharm Res; 2015 Nov; 38(11):2083-91. PubMed ID: 26254792
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism.
Sauer JM; Ponsler GD; Mattiuz EL; Long AJ; Witcher JW; Thomasson HR; Desante KA
Drug Metab Dispos; 2003 Jan; 31(1):98-107. PubMed ID: 12485958
[TBL] [Abstract][Full Text] [Related]
14. Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro.
Cai J; Dai DP; Geng PW; Wang SH; Wang H; Zhan YY; Huang XX; Hu GX; Cai JP
Basic Clin Pharmacol Toxicol; 2016 Mar; 118(3):190-9. PubMed ID: 26310775
[TBL] [Abstract][Full Text] [Related]
15. Assessment of 25 CYP2D6 alleles found in the Chinese population on propafenone metabolism in vitro.
Su Y; Liang BQ; Feng YL; Zhan Y; Gu E; Chen X; Dai DP; Hu GX; Cai JP
Can J Physiol Pharmacol; 2016 Aug; 94(8):895-9. PubMed ID: 27203132
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro.
Hu X; Lan T; Dai D; Xu RA; Yuan L; Zhou Q; Li Y; Cai J; Hu G
Drug Metab Dispos; 2016 Nov; 44(11):1828-1831. PubMed ID: 27538917
[TBL] [Abstract][Full Text] [Related]
17. In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese population.
Dai DP; Geng PW; Wang SH; Cai J; Hu LM; Nie JJ; Hu JH; Hu GX; Cai JP
Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):39-43. PubMed ID: 25469868
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro.
Fang P; Zheng X; He J; Ge H; Tang P; Cai J; Hu G
Drug Des Devel Ther; 2017; 11():1283-1290. PubMed ID: 28461741
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of 22 novel CYP2D6 variants for the metabolism of Tamoxifen.
Hu XX; Zhou Q; Lan T; Huang XX; Liang BQ; Dai DP; Cai JP; Hu GX
J Pharm Pharmacol; 2016 Jun; 68(6):819-25. PubMed ID: 27109434
[TBL] [Abstract][Full Text] [Related]
20. Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.
Brown JT; Bishop JR; Sangkuhl K; Nurmi EL; Mueller DJ; Dinh JC; Gaedigk A; Klein TE; Caudle KE; McCracken JT; de Leon J; Leeder JS
Clin Pharmacol Ther; 2019 Jul; 106(1):94-102. PubMed ID: 30801677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
